All In Biotech

Drug Trial Radar · NCT06841042

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

A Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SCTB35 in Patients with Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

168

Planned (sponsor's estimate)

Start

Feb 2025

Primary completion

May 2027

Study completion Oct 2028

Sponsor

Lead sponsor
Sinocelltech Ltd.Industry
Sponsor type
Industry
First posted
Feb 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).

Conditions

  • System Lupus Erythematosus

Interventions

  • SCTB35 injectionBiological

    SCTB35 will be subcutaneously administered at a dose as specified in the respective dose-escalation cohorts. Then, the RP2D and other appropriate doses of SCTB35 will be applied for the dose-expansion cohorts.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dose-escalation part: Incidence rate of adverse event (AE)Time frame: From first dose to the 24 weeks
  2. Dose-expansion part:SRI-4Time frame: Up to Week 24

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    Beijing, China · Recruiting

  • Xuanwu Hospital, Capital Medical University

    Beijing, China · Not yet recruiting

  • Jilin Provincial People's Hospital

    Changchun, China · Not yet recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, China · Not yet recruiting

  • Zhejiang Provincial People's Hospital

    Hangzhou, China · Not yet recruiting

  • The First People's Hospital of Jiujiang City

    Jiujiang, China · Not yet recruiting

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, China · Not yet recruiting

  • Linfen Central Hospital

    Linfen, China · Not yet recruiting

  • Mianyang Central Hospital

    Mianyang, China · Not yet recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China · Not yet recruiting

  • Pingxiang People's Hospital

    Pingxiang, China · Not yet recruiting

  • Shanxi Bethune Hospital

    Taiyuan, China · Not yet recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, China · Not yet recruiting

  • Xinxiang Central Hospital

    Xinxiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.